Ultragenyx Pharmaceutical Inc.
RARE •
Buy Open
Signal type
Buy
Status
Open
Open Price
$23.99
Stop Loss
$20.62
Performance
2.42%
Days Open
7
Signal Setup
Signal Type Buy
Status Open
Open Date Apr 8, 2026
Open Price $23.99
Stop Loss $20.62
Timespan Day
Company Profile
Name Ultragenyx Pharmaceutical Inc.
Ticker RARE
Market Cap $3.44B
Sector PHARMACEUTICAL PREPARATIONS
Latest Close $24.57
List Date Jan 31, 2014
Description
Ultragenyx Pharmaceutical Inc is a USA-based biopharmaceutical company. It identifies, acquires, develops, and commercializes novel products for the treatment of serious rare and ultra-rare diseases, with a focus on serious, debilitating genetic diseases. The company's medicine portfolio includes Crysvita, Dojolvi and Mepsevii. Crysvita is indicated for the treatment of X-linked hypophosphatemia (XLH) in adult and pediatric patients 1 year of age and older. Mepsevii is indicated in pediatric and adult patients for the treatment of Mucopolysaccharidosis VII.
Website Open Company Website